Acute venous disease: Venous thrombosis and venous trauma

被引:89
作者
Meissner, Mark H. [10 ]
Wakefield, Thomas W. [1 ]
Ascher, Enrico [2 ]
Caprini, Joseph A. [3 ]
Comerota, Anthony J. [4 ]
Eklof, Bo [5 ]
Gillespie, David L. [6 ]
Greenfield, Lazar J. [1 ]
Ruth, Aiwu
Henke, Peter K. [1 ]
Hingorani, Anil
Hull, Russell D. [7 ]
Kessler, Craig M.
McBane, Robert D. [8 ]
McLafferty, Robert [9 ]
机构
[1] Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA
[2] Maimonides Hosp, Div Vasc Surg, Brooklyn, NY 11219 USA
[3] NW Univ, Sch Med, Dept Surg, Evanston, IL USA
[4] NW Univ, Sch Med, Dept Surg, Springfield, IL USA
[5] Jobst Vasc Ctr, Toledo, OH USA
[6] Straub Fdn, Helsingborg, Sweden
[7] Uniformed Serv Univ Hlth Sci, Walter Reed Army Med Ctr, Potomac, MD USA
[8] Georgetown Univ, Med Ctr, Div Hematol Oncol, Ann Arbor, MI USA
[9] Georgetown Univ, Med Ctr, Dept Surg, Washington, DC 20007 USA
[10] Univ Washington, Sch Med, Dept Surg, Seattle, WA 98195 USA
关键词
D O I
10.1016/j.jvs.2007.08.037
中图分类号
R61 [外科手术学];
学科分类号
摘要
Acute venous disorders include deep venous thrombosis, superficial venous thrombophlebitis, and venous trauma. Deep venous thrombosis (DVT) most often arises from the convergence of multiple genetic and acquired risk factors, with a variable estimated incidence of 56 to 160 cases per 100,000 population per year. Acute thrombosis is followed by an inflammatory response in the thrombus and vein wall leading to thrombus amplification, organization, and recanalization. Clinically, there is an exponential decrease in thrombus load over the first 6 months, with most recanalization occurring over the first 6 weeks after thrombosis. Pulmonary embolism (PE) and the post-thrombotic syndrome (PTS) are the most important acute and chronic complications of DVT. Despite the effectiveness of thromboembolism prophylaxis, appropriate measures are utilized in as few as one-third of at-risk patients. Once established, the treatment of venous thromboembolism (VTE) has been defined by randomized clinical trials, with appropriate anticoagulation constituting the mainstay of management. Despite its effectiveness in preventing recurrent VTE, anticoagulation alone imperfectly protects against PTS. Although randomized trials are currently lacking, at least some data suggests that catheter-directed thrombolysis or combined pharmaco-mechanical thrombectomy can reduce post-thrombotic symptoms and improve quality of life after acute ileofemoral DVT. Inferior vena caval filters continue to have a role among patients with contra-indications to, complications of, or failure of anticoagulation. However, an expanded role for retrievable filters for relative indications has yet to be dearly established. The incidence of superficial venous thrombophlebitis is likely under-reported, but it occurs in approximately 125,000 patients per year in the United States. Although the appropriate treatment remains controversial, recent investigations suggest that anticoagulation may be more effective than ligation in preventing DVT and PE. Venous injuries are similarly under-reported and the true incidence is unknown. Current recommendations include repair of injuries to the major proximal veins. If repair not safe or possible, ligation should be performed.
引用
收藏
页码:25S / 53S
页数:29
相关论文
共 257 条
[1]   Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. [J].
Agnelli, G ;
Prandoni, P ;
Santamaria, MG ;
Bagatella, P ;
Iorio, A ;
Bazzan, M ;
Moia, M ;
Guazzaloca, G ;
Bertoldi, A ;
Tomasi, C ;
Scannapieco, G ;
Ageno, W ;
Ascani, A ;
Villalta, S ;
Frulla, M ;
Mosena, L ;
Girolami, A ;
Vaccarino, A ;
Alatri, A ;
Palareti, G ;
Marchesi, M ;
Ambrosio, GB ;
Parisi, R ;
Doria, S ;
Steidl, L ;
Ambrosini, F ;
Silingardi, M ;
Ghirarduzzi, A ;
Iori, I .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) :165-169
[2]  
AITA DJ, 1993, AM SURGEON, V59, P574
[3]   LOWER-LIMB VEIN TRAUMA - A LONG-TERM CLINICAL AND PHYSIOLOGICAL ASSESSMENT [J].
AITKEN, RJ ;
MATLEY, PJ ;
IMMELMAN, EJ .
BRITISH JOURNAL OF SURGERY, 1989, 76 (06) :585-588
[4]  
Akesson H, 1990, Eur J Vasc Surg, V4, P43, DOI 10.1016/S0950-821X(05)80037-4
[5]   THE PREVALENCE OF RISK-FACTORS FOR VENOUS THROMBOEMBOLISM AMONG HOSPITAL PATIENTS [J].
ANDERSON, FA ;
WHEELER, HB ;
GOLDBERG, RJ ;
HOSMER, DW ;
FORCIER, A .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (08) :1660-1664
[6]   A POPULATION-BASED PERSPECTIVE OF THE HOSPITAL INCIDENCE AND CASE-FATALITY RATES OF DEEP-VEIN THROMBOSIS AND PULMONARY-EMBOLISM - THE WORCESTER DVT STUDY [J].
ANDERSON, FA ;
WHEELER, HB ;
GOLDBERG, RJ ;
HOSMER, DW ;
PATWARDHAN, NA ;
JOVANOVIC, B ;
FORCIER, A ;
DALEN, JE .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (05) :933-938
[7]   PHYSICIAN PRACTICES IN THE PREVENTION OF VENOUS THROMBOEMBOLISM [J].
ANDERSON, FA ;
WHEELER, HB ;
GOLDBERG, RJ ;
HOSMER, DW ;
FORCIER, A ;
PATWARDHAN, NA .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (08) :591-595
[8]   The pharmacology and management of the vitamin K antagonists [J].
Ansell, J ;
Hirsh, J ;
Poller, L ;
Bussey, H ;
Jacobson, A ;
Hylek, E .
CHEST, 2004, 126 (03) :204S-233S
[9]   PRELIMINARY-RESULTS OF A NONOPERATIVE APPROACH TO SAPHENOFEMORAL JUNCTION THROMBOPHLEBITIS [J].
ASCER, E ;
LORENSEN, E ;
POLLINA, RM ;
GENNARO, M .
JOURNAL OF VASCULAR SURGERY, 1995, 22 (05) :616-621
[10]  
Ascher E, 1999, J ENDOVASC SURG, V6, P365, DOI 10.1583/1074-6218(1999)006<0365:CEWSVC>2.0.CO